transmission security (HIPAA)

Covered entities must address transmission security as part of their technical safeguards. The Security Rule defines it as "technical security mechanisms to guard against unauthorized access to electronic protected health information [PHI] that is being transmitted over an electronic communications network."

The standard has two implementation specifications, both of which are addressable:

  • integrity controls, and
  • encryption.

The first includes "security measures to ensure that electronically transmitted electronic protected health information is not improperly modified without detection until disposed of." The second embraces "mechanisms to encrypt electronic [PHI] deemed appropriate."

The standard does not mandate any particular set of integrity controls, such as encryption, for all transmissions. (In a proposed version of the Rule, encryption was to be required for all "open networks.") Now the covered entity must decide, following its own risk analyses, what degree of protection is appropriate in each circumstance.

While it "encourages" consideration of encryption, DHHS has advised only that electronic PHI must be "protected in a manner commensurate with the associated risk" when it is transmitted from one place to another. (Final Rule, p.139) Technological change can be expected to shift both the cost-effectiveness of encryption technologies as well as the risk factors for interception of unencrypted transmissions.

In response to questions regarding unsolicited electronic receipt of PHI -- e.g., in email from patients -- DHHS offered the following guidance: "[S]ecurity protection must subsequently be afforded ... once that information is in the possession of the covered entity," commensurate with its nature and sensitivity. "The manner in which the information is received does not affect the protection required." (Final Rule, p.144) However, the Rule does not require covered entities to try to protect the unsolicited inbound transmissions.

This leaves open the question of whether, as a matter of ethics, covered entities should encourage or discourage certain transmission behaviors by patients. But HIPAA does not require that covered entities treat patients like business associates and insist on security at the patient's end of the wire.

See also:

 
 

   © 2002-2006 Contributing authors and University of Miami School of Medicine